Huntington Ellis Rolls Smart to Boost Agent Performance
Huntington & Ellis launches Smart by h&e, an in-house AI assistant designed to streamline deals, draft communications...
Which Index Fund Has Better Rolling Returns
Determine which index fund delivers stronger rolling returns using straightforward comparisons and key performance signals.
28,124 articles
India Brings Back COVID-Era Work Rules Amid Oil Turmoil
India pivots to telework and reduced travel as Iran-related oil disruptions strain energy supplies. The government al...
Qualcomm Bears Could Missing a Major Rebound in Tech Stocks
Qualcomm has vaulted from March lows as auto and IoT growth accelerates. Yet market skeptics linger, with hyperscaler...
CAB, Europol Secure 500 BTC Linked to Irish Drug Case
Irish authorities, aided by Europol, seized 500 BTC from a second dormant wallet tied to a long-running Irish drug tr...
Tether’s $141 Billion Treasury Pile Shocks Markets
Tether’s growing US Treasury stash has vaulted the stablecoin issuer into the ranks of major debt holders. The develo...
Worth Investing Ethereum (ETH) Right Now: A 2026 View
Ethereum’s bounce prospects hinge on institutional access and policy clarity. A new staking ETF and rising regulatory...
Scrolling UBI Boosts Deloitte’s Fastest-Growing Software Firm
A mobile app rewards users for scrolling, propelling Mode Mobile into Deloitte’s fastest-growing software roster. Sha...
SpaceX Breaks IPO Playbook with Fixed-Price Offering
SpaceX priced its IPO at a fixed $135 per share, aiming to raise roughly $75 billion and valuing the company around $...
TON Strategy’s May Staking Haul Tops 3.3M TON Upgrades
TON Strategy’s May staking haul tops 3.3M TON as network upgrades take effect, with roughly $5.6 million in May rewar...
Rechat Adds Custom Building Features for Apps Today
Rechat expands its platform to let brokerages, teams, and vendors build branded apps atop its real estate OS. The fea...
Domo (domo) 2027 Earnings: Market Outlook, Growth & Risks
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status